1. Cholesterol esterscation has been studied in the plasma of subjects on diets rich in saturated or polyunsaturated fat.
Introduction
Most of the plasma cholesteryl esters in man are probably synthesized within the plasma (Glomset, 1968) under the influence of lecithin-cholesterol acyltransferase(EC2.3.1.43), butlittleis knownof the factors that regulate plasma LCAT'') activity. Relationships to several variables have been reported, (') Abbreviations : LCAT, lecithin-cholesterol acyltransferase; PIS ratio, ratio of polyunsaturated fat to saturated fat.
Correspondence : Dr J. P. Miller duced plasma cholesterol esterscation in vitro when polyunsaturated fat was substituted for saturated fat in the diet. However, it is not clear from their study whether there was any change in LCAT activity since their assay reflects changes in both enzyme activity and in its lipoprotein substrates.
To gain information about those factors that regulate plasma LCAT activity, we have studied fifteen subjects on diets rich in saturated and unsaturated fat, using methods designed to detect changes mediated by alterations in enzyme activity and substrate composition.
Methods

Subjects and diets
Fifteen male subjects (aged 20-63 years) were studied as out-patients. The group comprised normal subjects and patients with endogenous hypertriglyceridaemia and hypercholesterolaemia. None was taking drugs affecting lipid metabolism and causes of secondary hyperlipidaemia had been excluded. Both diets consisted of ordinary foodstuffs, and full details are given by Chait, Onitiri, Nicoll, Rabaya, Davies & Lewis (1974) . Each dietary period was 7-9 days, one diet having a ratio of polyunsaturated to saturated fat (P/S ratio) of 0.2. During the other dietary a period, saturated fat was replaced by an energyequivalent amount of polyunsaturated fat to give a PIS ratio of 2.4. Body weights were constant to k 1 kg on the diets.
Analyses and assays
Lipid. Triglycerides and total cholesterol were determined in propan-2-01 extracts of plasma by semiautomated methods (Cramp & Robertson, 1968; Technicon procedures N-78 and N-24a) . The method of determining the percentage of plasma cholesterol esterified has been described previously .
Assays of LCAT. The estimation of cholesterol esterification in vitro was based on the method of Glomset &Wright (1964) and has been described by . Two modifications were made, in that substrate lipoproteins were preincubated with radioactive cholesterol for 4 h and the total incubation volume was reduced to 1 ml. Thus incubation mixtures contained 0.9 ml of substrate (0.8 ml of heat-inactivated plasma and 0.1 ml of a suspension of [4-14C]cholesterol in albumin) and 0.1 ml of active plasma (LCAT source). The mixture was incubated for 3 h, during which esterification was linear. Three series of incubations were performed. All incubations (including blank non-LCAT-containing incubations) were performed in duplicate and results are expressed as m o l of cholesterol esterified per h per ml of LCAT source.
(a) Series I assays. These assays were designed to determine the activity of LCAT in the patients' plasmas on the two diets. Active plasma (0.1 ml) from each experimental subject was assayed against 0.9 ml of 'standard substrate' (a pool of heat-inactivated labelled plasma from several normal subjects).
(b) Series I1 assays. The aim of these assays was to determine if alteration in the composition of the dietary fat had influenced the ability of the subjects' plasma samples to act as LCAT substrates. Substrate (0.9 ml), prepared from the plasma of the experimental subjects, was used in assays containing 0.1 ml of 'standard LCAT' (pooled active plasma from several normal subjects).
(c) Series I11 assays. These assays were performed to see if the alterations in substrate efficiency detected in the series I1 assays were quantitatively sufficiently great to have made an appreciable contribution to the changes observed in the series I assays. 'Standard LCAT' was assayed against 'standard substrate', the latter having been modified by addition of 0.1 m1 of heat-inactivated experimental plasma.
Results
Plasma lipids
The polyunsaturated fat diet was associated with significantly lower (P< 0.001) plasma concentrations of cholesterol (mean 5.37 mmol/l, SEM 0.28) and triglycerides (1.40 mmol/l, SEM 0.21) than the saturated fat diet (6.41, SEM 0.34, and 2.34, SEM 0.42, respectively). The percentage of plasma cholesterol esterified was essentially the same on the polyunsaturated (71.1, SEM 0-7) and saturated fat diets (715, s~~0 . 8 ) .
Assays of LCAT
Results of the LCAT assays (series 1-111) are shown in Fig. 1 . Data are available for only thirteen subjects in the series I1 assays and fourteen subjects in the series I11 assays. The diet rich in polyunsaturated fat was associated with a significant reduction(P< 0.001) in esterification in the series I assays from a mean of 27.1 nmol h-' ml-(SEM 1.3) to 22.6 (SEM 1-5). In the series I1 assays esterification was also significantly reduced (P<O.001) from 48.5 (SEM 3.0) to 37.2 (SEM 2.9). In the series I11 assays, however, esterification was very similar (P>O.l) on the diets rich in saturated (mean 22.7, SEM 0.4) and unsaturated (mean 22.5, SEM 0.4) fat. Indeed, not only was esterification very similar for a given subject on each diet in the series 111 assays but there was very little between-subject variation.
Discussion
The results of the series I1 assays show that when the unsaturation of dietary fat is increased there is a reduction in the ability of plasma to support esterification by a given LCAT source. The series I assays point to a reduction in plasma LCAT activity under the same circumstances, but an element of doubt persists because of the small contribution made by the LCAT source to overall substrate composition in these assays. However, in the series I11 assays, where a 'standard LCAT' source was used and the substrates were similar in composition to those of the series I assays, there was no significant 'between-diet' difference in esterscation. Thus it seems there is a genuine reduction in plasma LCAT activity on high P/S diets, though we cannot say whether enzyme or substrate is rate limiting in a given situation.
This phenomenon may prove to be of considerable practical importance in view of the widespread use of high PIS diets in the treatment of hyperlipidaemias and the suggestions that the role of the high-density lipoprotein-LCAT system is to remove cholesterol from cell membranes (Glomset & Norum, 1973 ) and arterial wall (Rutenberg & Soloff, 1971) .
On theoretical grounds, Schumaker & Adams (1 970) postulated a decreased requirement for cholesterol esterification when plasma triglyceride turnover is reduced. The present work seems to fit this concept since we have demonstrated reduced esterscation on high P/S diets and Chait et al. (1974), studying a similar group of subjects under identical conditions, produced evidence that such diets are associated with reduced secretion or endogenous triglyceride into plasma. This has been confirmed more directly in rats (Morris, Chait, Cohen & France, 1975) . Other work (Miller, 1975) suggests that variables influenced by cholestyramine resin therapy, such as hepatic cholesterol synthesis or plasma concentrations of cholesterol or low-density lipoproteins, do not influence esterification. Thus it seems that interrelationships with triglyceride metabolism deserve further study in future work on the regulation of plasma LCAT activity.
